<?xml version="1.0" encoding="UTF-8"?>
<p id="p0140">It is important to note that remdesivir (
 <bold>1</bold>), the most probable drug according to new information from clinical studies [
 <xref rid="bib49" ref-type="bibr">49</xref>,
 <xref rid="bib50" ref-type="bibr">50</xref>,
 <xref rid="bib100" ref-type="bibr">100</xref>], has a similar MW (616 Da), the highest TPSA value (203.57 Å
 <sup>2</sup>) and exhibits an ideal partition coefficient between polar and lipid layers (cLogP = 2.12), but its absorption (38%) is the worst among the selected drugs. More precisely, this nucleotide analog prodrug, which inhibits viral RNA polymerase, is only administered intravenously, and compassionate use in treatment of patients hospitalized for severe Covid-19 showed clinical improvement [
 <xref rid="bib101" ref-type="bibr">101</xref>].
</p>
